Study indicates that fathers who exercise before conception produce children who are healthier throughout their lives – Joslin Diabetes Center – Recent studies. Guías ALAD sobre el diagnóstico, control y tratamiento de la Diabetes Mellitus Tipo 2 con medicina basada en evidencia. Edición Global estimates of diabetes prevalence for and projections for .. Guías ALAD de diagnóstico, control y tratamiento de la diabetes mellitus tipo 2.

Author: Voodoozragore JoJom
Country: Saint Lucia
Language: English (Spanish)
Genre: Technology
Published (Last): 28 April 2008
Pages: 477
PDF File Size: 13.81 Mb
ePub File Size: 5.14 Mb
ISBN: 228-8-85793-301-1
Downloads: 21151
Price: Free* [*Free Regsitration Required]
Uploader: JoJolar

Diabet Med1: Med Sci Sports Exerc. BMC Endocr Disord ; Herman W, Johnson J, et al. Use of a claims-based active drug safety surveillance mellotus to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide. Rosiglitazone monotherapy is effective in patients with type 2 diabetes. Revista de la ALAD, Beneficial effect on average lipid levels from energy restriction and fat loss in obese individuals with or without type 2 diabetes.

Current global guidelines for type 2 diabetes treatment

Separate influence of dietary carbohydrate and fibre on the metabolic control in diabetes. Am J Clin Nutr If non-insulin monotherapy at maximum tolerated dose does not achieve or maintain the HbA1c target over 3 months, a second oral agent — a glucagon-like peptide-1 receptor agonist or basal insulin — can be added. Clarifying metformin’s role and risks in liver dysfunction.


Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years.

Independent and additive effects of energy restriction and exercise on glucose and insulin concentrations in sedentary overweight men. Dual add-on therapy in type 2 diabetes poorly controlled with metformin monotherapy: Egan A, Blind E, et al.

Revista de la Sociedad Argentina de Diabetes http: Management of hyperglycemia in type 2 diabetes: Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. Ann Intern Med Dipeptidylpeptidase 4 DPP-4 inhibitors for type 2 diabetes mellitus.

Cochrane Database Syst Rev.

J Hum Hypertens ; Comparison of high and lowglycemicindex breakfast cereals with monounsaturated fat in the long-term dietary management of type 2 diabetes. At last, a weight neutral insulin? Diabetes, obesity and metabolism ddiabetes, A week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes. Bailey C, Turner R.

Diabetes Metab ; Dietary advice for treatment of type 2 diabetes mellitus in adults;Pub 3, CD, Diabetes Care ; Management of hyperglycemia in type 2 diabetes, The ultimate goal meloitus T2DM treatment is to achieve optimal glycaemic control with available resources. Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on diabwtes monotherapy: Herman W, et al. Socio-economic aspects are important considerations in the preparation of T2DM treatment algorithms.


Lifestyle interventions such as diet and exercise can be effective, but are often insufficient for long-term maintenance of normoglycaemia. N Alae J Med ; Clinical experience with this agent is limited.

ALAD recommendations for Latin America7 Start treatment with oral antidiabetic agents in everyone with T2DM who has not achieved their glycaemic goals after 3—6 months of lifestyle modifications.

Current global guidelines for type 2 diabetes treatment | Manage Diabetes Online

J Manag Care PharmCost-effectiveness of insulin analogues for diabetes mellitus, CMAJ ; 4: The incretins from the concept to their use in the treatment of type 2 diabetes. International Diabetes Federation; Metformin prevents weight gain by reducing dietary intake during insulin therapy in patients with type 2 diabetes mellitus. Am J Clin Nutr diaberes 67 Suppl 1: Determinants for the effectiveness of lifestyle intervention in the Finnish Diabetes Prevention Study.